X0508 4 2024-03-01 0001781174 Acrivon Therapeutics, Inc. ACRV 0001950551 Gamelin Erick C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 true Chief Development Officer false Stock Option (Right to Buy) 5.7 2024-03-01 4 A 0 45045 0 A 2034-02-28 Common Stock 45045 45045 D Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2025, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date. /s/ Rasmus Holm-Jorgensen, Attorney-in-Fact 2024-11-27